Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Harrow, Inc. - Common Stock (NQ: HROW )

34.03 -0.52 (-1.49%)
Streaming Delayed Price Updated: 10:05 AM EST, Jan 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Harrow, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Harrow Health, Inc. Changes Corporate Name to Harrow, Inc.
From Harrow Health, Inc.
Via Business Wire
Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis® Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural Sedation
From Melt Pharmaceuticals, Inc.
Via Business Wire
Harrow Announces Second Quarter 2023 Financial Results
From Harrow Health, Inc.
Via Business Wire
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 5/30
Via Investor Brand Network
Recap: Harrow Health Q1 Earnings
Via Benzinga
Earnings Preview For Harrow Health
Via Benzinga
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 5/9
Via Investor Brand Network
Harrow Launches VIGAMOX® in the U.S.
From Harrow Health, Inc.
Via Business Wire
Harrow to Announce Second Quarter 2023 Financial Results on August 9, 2023
From Harrow Health, Inc.
Via Business Wire
Nasdaq Moves Lower; US Crude Oil Inventories Decline Less Than Projected
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.31% to 35,058.78 while the NASDAQ fell 0.21% to 14,323.99. The S&P 500, also... 
Via Benzinga
Harrow Health Inc. (NASDAQ: HROW) is a Stock Spotlight on 5/1
Via Investor Brand Network
Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Crude Oil Up 1%; M&T Bank Posts Upbeat Q2 Results
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.5% on Wednesday. The Dow traded up 0.53% to 35,137.16 while the NASDAQ rose 0.48% to 14,422.74. The S&P 500,... 
Via Benzinga
Why Shares of Harrow Health Are Jumping Wednesday
The company increased guidance, acquired a company, and had a stock sale. 
Via The Motley Fool
Why Harrow Health Stock Is Trading Higher Today?
Harrow Health Inc (NASDAQ: HROW) agreed to acquire the U.S. and Canadian commercial rights for Vevye (cyclosporine ophthalmic solution) 0.1%, a non‑preserved from Novaliq GmbH. 
Via Benzinga
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Harrow Prices $60 Million Public Offering of Common Stock
From Harrow Health, Inc.
Via Business Wire
Harrow Acquires Santen’s Branded Ophthalmic Portfolio
From Harrow Health, Inc.
Via Business Wire
Harrow Provides Select Preliminary Second Quarter 2023 Financial Guidance
From Harrow Health, Inc.
Via Business Wire
Harrow Announces Proposed Public Offering of Common Stock
From Harrow Health, Inc.
Via Business Wire
Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® (Cyclosporine Ophthalmic Solution) 0.1% from Novaliq
From Harrow Health, Inc.
Via Business Wire
Harrow to Participate in B. Riley Securities 23rd Annual Institutional Investor Conference on May 24, 2023
From Harrow
Via Business Wire
NASDAQ:HROW Shareholder Notice: Investigation over Possible Breaches of Fiduciary Duties at Harrow Health, Inc
San Diego, CA -- (SBWIRE) -- 05/16/2023 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Harrow Health, Inc. 
Via SBWire
Why Shares of Harrow Health Are Slumping Friday
The pharmaceutical company announced first-quarter earnings Thursday afternoon. 
Via The Motley Fool
Harrow Announces First Quarter 2023 Financial Results
From Harrow Health, Inc.
Via Business Wire
Why Heron Therapeutics Shares Are Trading Lower By 34%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers GSI Technology, Inc. (NASDAQ: GSIT) shares surged 108% to $3.4207. GSI Technology is expected to announce financial results for its fiscal fourth quarter after the market close on May 16,... 
Via Benzinga
Harrow to Launch FDA-Approved IHEEZO™ at the 2023 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
From Harrow
Via Business Wire
Harrow Launches ILEVRO®, NEVANAC®, and MAXIDEX® in the U.S.
From Harrow
Via Business Wire
Harrow to Announce First Quarter 2023 Financial Results on May 11, 2023
From Harrow
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.